YLKTT, a potent biopeptide that ameliorates oxygen-glucose deprivation-induced neuronal cell ferroptosis by ACSL4/GPX4 and SLC7A11/GPX4 axis
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Yujie Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Hauptthemen laut MEDLINE: Ferroptosis, Phospholipid Hydroperoxide Glutathione Peroxidase, Amino Acid Transport System y+, Neurons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, Science and Technology Program of Tianjin.
Abstract (Originalsprache)
Objectives
Shuxuetong injection (SXT) treats cerebral ischemic injury by inhibiting apoptosis. However, the specific active ingredient responsible for this effect and its mechanism of action remain unclear.
Methods
In previous research, we identified the small peptide YLKTT in SXT, which has shown protective effects on astrocytes subjected to oxygen-glucose deprivation/reoxygenation (OGD/R). In this study, we utilized transcriptomics technology to predict the specific target genes and pathways of YLKTT in the context of stroke treatment. We further validated these predictions through RT-PCR, lipid peroxidation assays, Western blotting, and other related methods. Key findings The transcriptomics results indicated that YLKTT could further alleviate ischemia-reperfusion injury by inhibiting ferroptosis, with the specific pathway likely involving the regulation of glutathione peroxidase 4 (GPX4) by ACSL4 and SLC7A11. Experimental results demonstrated that YLKTT interfered with the SLC7A11/GPX4 and ACSL4/GPX4 pathways, thereby enhancing antioxidant capacity, inhibiting the accumulation of lipid peroxidation, and ultimately reversing OGD-induced ferroptosis. Additionally, erastin significantly reduced SLC7A11 mRNA and protein levels and decreased GPX4 levels, while YLKTT was able to reverse these changes.
Conclusions
YLKTT can exert anti-ferroptosis effects through the ACSL4/GPX4 and SLC7A11/GPX4 pathways, thereby improving the treatment of cerebral ischemic injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Tianjin Key Laboratory of Intelligent and Green Pharmaceuticals for Traditional Chinese Medicine, State Key Laboratory of Chinese Medicine Modernization, Haihe Laboratory of Modern Chinese Medicine, Tianjin University o…
- Department of Pharmaceutics,Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin300162, China.
- Military Medicine Section, Department of Health Services, Logistics University of Chinese People's Armed Police Force, 1 Huizhihuan Road, Dongli District, Tianjin 300309, China.
- School of Chemistry, Tianjin Normal University, Tianjin 300387, China.
ORCID-Profile: Rui Liu
Förderung
- National Natural Science Foundation of China
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- Science and Technology Program of Tianjin
- Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine
- Innovation Research Project of Chinese People's Armed Police Force
- Program for Science and Technology of Logistics University of Chinese People's Armed Police Force
- Innovation Research Project of Chinese People’s Armed Police Force
- Program for Science and Technology of Logistics University of Chinese People’s Armed Police Force
Zitieren
APA
Wu, Y., Ji, Y., Jin, X., Xu, G., Wang, X., Song, S., Li, R., Wang, Y., Liu, R., & Li, Z. (2025). YLKTT, a potent biopeptide that ameliorates oxygen-glucose deprivation-induced neuronal cell ferroptosis by ACSL4/GPX4 and SLC7A11/GPX4 axis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf037
Vancouver
Wu Y, Ji Y, Jin X, Xu G, Wang X, Song S, et al. YLKTT, a potent biopeptide that ameliorates oxygen-glucose deprivation-induced neuronal cell ferroptosis by ACSL4/GPX4 and SLC7A11/GPX4 axis. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf037
BibTeX
@article{Wu2025,
author = {Wu, Yujie and Ji, Yansu and Jin, Xin and Xu, Guangjing and Wang, Xiaoyu and Song, Saisai and Li, Rui and Wang, Yuhan and Liu, Rui and Li, Zheng},
title = {YLKTT, a potent biopeptide that ameliorates oxygen-glucose deprivation-induced neuronal cell ferroptosis by ACSL4/GPX4 and SLC7A11/GPX4 axis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf037}
}
EUVIMED